Valproyl‐CoA inhibits the activity of ATP‐ and GTP‐dependent succinate:CoA ligases-Reference-Cited by-同舟云学术

Valproyl‐CoA inhibits the activity of ATP‐ and GTP‐dependent succinate:CoA ligases

Published:2013-10-24 Issue:3 Volume:37 Page:353-357
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:Jrnl of Inher Metab Disea

Author:

Luís Paula B. M.¹²,Ruiter Jos²,IJlst Lodewijk²,Almeida Isabel Tavares¹³,Duran Marinus²,Wanders Ronald J. A.²,Silva Margarida F. B.¹³

Affiliation:

1. Research Institute for Medicines and Pharmaceutical Sciences – iMED.ULFaculty of Pharmacy, University of LisbonAv. Prof. Gama PintoLisboa1649‐003Portugal

2. Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry and Pediatrics, Academic Medical CentreUniversity of AmsterdamMeibergdreef 9Amsterdam1105 AZThe Netherlands

3. Department of Biochemistry and Human Biology, Faculty of PharmacyUniversity of LisbonAv. Prof. Gama PintoLisboa1649‐003Portugal

Funder

Fuel Cycle Technologies

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1007/s10545-013-9657-4

Reference41 articles.

1. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis

2. New insights on the mechanisms of valproate‐induced hyperammonemia: inhibition of hepatic N‐acetylglutamate synthase activity by valproyl‐CoA;Aires CC;J Hepatol,2010

3. Depletion of mtDNA: Syndromes and genes

4. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity

5. Thymidylate nucleotide supply for mitochondrial DNA synthesis in mouse L-cells. Effect of 5-fluorodeoxyuridine and methotrexate in thymidine kinase plus and thymidine kinase minus cells.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic and Toxic Effects of Valproic Acid Metabolites;Metabolites;2023-01-16

2. Inborn errors of mitochondrial acyl-coenzyme a metabolism: acyl-CoA biology meets the clinic;Molecular Genetics and Metabolism;2019-09

3. Hyperammonemic encephalopathy without hepatic dysfunction due to treatment with valproate: four cases and a mini review;Psychiatry and Clinical Psychopharmacology;2018-03-28

4. Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase;International Journal of Molecular Sciences;2017-09-06

5. Drug induced mitochondrial dysfunction: Mechanisms and adverse clinical consequences;Mitochondrion;2016-11